Cardiovascular pharmacotherapy in older people: challenges posed by cardiovascular drug prescription in the elderly

Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):277-279. doi: 10.1093/ehjcvp/pvaa090.

Authors

Juan Carlos Kaski¹, Juan Tamargo², Gianluigi Savarese³

Affiliations

¹ Molecular and Clinical Sciences Research Institute, St George's, University of London, Cranmer Terrace, London SW17 0RE, UK.
² Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid, Spain.
³ Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

PMID: 32687147
DOI: 10.1093/ehjcvp/pvaa090

No abstract available

MeSH terms

Age Factors
Aged
Aged, 80 and over
Aging*
Cardiovascular Agents / adverse effects
Cardiovascular Agents / therapeutic use*
Cardiovascular Diseases / drug therapy*
Drug Interactions
Drug Prescriptions
Drug-Related Side Effects and Adverse Reactions / etiology
Female
Humans
Male
Medication Adherence*
Polypharmacy

Substances

Cardiovascular Agents